|
|
| | Androst-5-en-17-one, 3,7,15-trihydroxy-, (3beta,7alpha,15alpha)- (9CI) Basic information |
| Product Name: | Androst-5-en-17-one, 3,7,15-trihydroxy-, (3beta,7alpha,15alpha)- (9CI) | | Synonyms: | Androst-5-en-17-one, 3,7,15-trihydroxy-, (3beta,7alpha,15alpha)- (9CI);(3beta,7alpha,15alpha)-3,7,15-Trihydroxy-androst-5-en-17-one;Androst-5-en-17-one, 3,7,15-trihydroxy-, (3beta,7alpha,15alpha);3b,7a,15a-Trihydroxyandrost-5-en-17-one;7α, 15α-Dihydroxyandrostenolone;Trihydroxybutan matter;3,7,15-trihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one;(3B,7A,15A)-3，7, 15- DIHYDROXYANDROSTENOLONE 2963-69-1 | | CAS: | 2963-69-1 | | MF: | C19H28O4 | | MW: | 320.42 | | EINECS: | 608-385-2 | | Product Categories: | STEROID | | Mol File: | 2963-69-1.mol |  |
| | Androst-5-en-17-one, 3,7,15-trihydroxy-, (3beta,7alpha,15alpha)- (9CI) Chemical Properties |
| Boiling point | 517.5±50.0 °C(Predicted) | | density | 1.26±0.1 g/cm3(Predicted) | | vapor pressure | 0.001Pa at 25℃ | | storage temp. | 2-8°C | | pka | 13.77±0.70(Predicted) | | LogP | 0.97 at 25℃ and pH7 |
| | Androst-5-en-17-one, 3,7,15-trihydroxy-, (3beta,7alpha,15alpha)- (9CI) Usage And Synthesis |
| Uses | Progestin therapeutic |
| | Androst-5-en-17-one, 3,7,15-trihydroxy-, (3beta,7alpha,15alpha)- (9CI) Preparation Products And Raw materials |
|